Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Sell
7,912
-1,979
-20% -$223K 0.16% 99
2025
Q4
$1.24M Buy
9,891
+595
+6% +$75.8K 0.23% 76
2025
Q3
$1.25M Buy
9,296
+7,445
+402% +$977K 0.25% 73
2025
Q2
$252K Buy
1,851
+89
+5% +$11.7K 0.06% 132
2025
Q1
$234K Sell
1,762
-15
-0.8% -$1.91K 0.06% 151
2024
Q4
$201K Sell
1,777
-105
-6% -$12.1K 0.05% 154
2024
Q3
$215K Buy
+1,882
New +$206K 0.05% 154
2024
Q2
Sell
-1,823
Closed -$207K 144
2024
Q1
$207K Sell
1,823
-42
-2% -$4.82K 0.05% 147
2023
Q4
$205K Buy
+1,865
New +$186K 0.05% 153
2023
Q3
Sell
-1,859
Closed -$203K 157
2023
Q2
$203K Buy
+1,859
New +$198K 0.06% 158
2023
Q1
Sell
-1,969
Closed -$216K 159
2022
Q4
$216K Buy
+1,969
New +$204K 0.07% 150

Other funds holding ABT

Legacy Trust's ABT Position: Q1 2026 in Review

Legacy Trust reduced its Abbott (ABT) stake by 20% in Q1 2026, selling an estimated $223K and leaving 7,912 shares worth $812K. The position accounts for 0.16% of the portfolio, ranked #99.

Legacy Trust first reported a position in ABT in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.25M in Q3 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Legacy Trust held 7,912 shares of Abbott worth $812K as of Q1 2026.
  • Legacy Trust sold 1,979 Abbott shares in Q1 2026, an estimated $223K.
  • Abbott made up 0.16% of Legacy Trust's portfolio in Q1 2026, its #99 holding.
  • Legacy Trust first reported a position in Abbott in Q4 2022 and has held it in 11 quarters since.
  • Legacy Trust's Abbott position peaked at $1.25M in Q3 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.